Suchergebnisse - "Faries, Mark B."

PubPharm (314)

11

Regarding: Predicting Regional Lymph Node Recurrence in The Modern Age of Tumor-Positive Sentinel Node Melanoma

enthalten in: Annals of surgical oncology | 2023

von Thompson, J. | Hyngstrom, J. | Caracò, C. | +44

12

Regarding: Predicting Regional Lymph Node Recurrence in The Modern Age of Tumor-Positive Sentinel Node Melanoma

enthalten in: Annals of surgical oncology | 2023

von Thompson, J. | Hyngstrom, J. | Caracò, C. | +44

13

Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology : a randomized clinical trial

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Adams, A. | Carpenter, E. | Clifton, G. | +18

14

Re : "Time to reconsider the role of sentinel lymph node biopsy in melanoma"

enthalten in: Journal of the American Academy of Dermatology | 2023

von Faries, M. | Cochran, A. | Thompson, J.

CommentOn: J Am Acad Dermatol. 2019 Apr;80(4):1168-1171. - PMID 30471314

15

Patterns of recurrence and prognosis in pathologic stage I and II Merkel cell carcinoma : A multicenter, retrospective cohort analysis

enthalten in: Journal of the American Academy of Dermatology | 2023

von Tieniber, A. | Shannon, A. | Carr, M. | +16

16

Sentinel lymph node biopsy in patients with T1a cutaneous malignant melanoma : A multicenter cohort study

enthalten in: Journal of the American Academy of Dermatology | 2023

von Shannon, A. | Sharon, C. | Straker, R. | +14

17

Response to 'Multicentre Selective Lymphadenectomy Trial 1 : key primary data remain unavailable'

enthalten in: The British journal of dermatology | 2022

von Faries, M. | Cochran, A. | Thompson, J.

CommentOn: Br J Dermatol. 2022 Dec;187(6):997-998. - PMID 35730244

18

An Internally Validated Prognostic Risk-Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma

enthalten in: Annals of surgical oncology | 2022

von Shannon, A. | Straker, R. | Carr, M. | +17

19

ASO Author Reflections : Minimally Invasive Inguinal Lymphadenectomy, an Incremental Step in the Evolution of the Management of Advanced Melanoma

enthalten in: Annals of surgical oncology | 2022

von Jakub, J. | Faries, M.

CommentOn: Ann Surg Oncol. 2022 Sep;29(9):5910-5920. - PMID 35499783

20

Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in the Second Multicenter Selective Lymphadenectomy Trial (MSLT-II)

enthalten in: Annals of surgical oncology | 2022

von Jakub, J. | Lowe, M. | Howard, J. | +21

CommentIn: Ann Surg Oncol. 2022 Sep;29(9):5921-5922. - PMID 35501584